GE HealthCare to acquire Sofie Biosciences for $945M

GE HealthCare announced a $945 million acquisition of Sofie Biosciences to expand its capabilities in radiopharmaceutical manufacturing and distribution for PET imaging applications. The acquisition strengthens GE's position in nuclear medicine technology.